← Leaderboards
Jin Chen
University Of California, San Francisco
$566,263
Attributed
$566,263
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $249K · FY2019–22$250K$187.5K$125K$62.5K$0
'19
'20
'21
'22
Funding mix
By agency
NIH$566,263 · 2
By mechanism
R00$416,263 · 1
K99$150,000 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Davide Ruggero$27,506,499
- Anita Sil$24,389,913
- Maria Barna$13,342,257
- Donna M. Ferriero$20,040,301
- William A Weiss$31,543,847
Others in their field
Other Emerging Leaders on “Biochemical”
- John Damon Chodera · Sloan-Kettering Inst Can Research$47,159,667
- Ashlin Bolton · Broad Institute, Inc.$19,699,069
- Robert J Woods · Virginia Polytechnic Institute And State University$12,760,318
- Bryan Roth · Univ Of North Carolina Chapel Hill$12,367,722
- Anna Upton · Global Alliance For Tb Drug Development$10,496,979
- Neil King · University Of Washington$9,764,305
Research focus
BiochemicalBiologicalBiological ModelsBiologyBiophysicsCell LineCell PhysiologyCellsCell SurvivalCell TransformationCellular StressClustered Regularly Interspaced Short Palindromic RepeatsCo-ImmunoprecipitationsComplementCrispr/Cas TechnologyCrispr ScreenDeep SequencingDesignEventExperimental StudyFollow-UpFrap1 GeneFunctional GenomicsBase
Grant awards (4)
Defining the regulatory roles of alternative ribosome initiation and novel peptides$167,264
R00 · FY2022 · GM · contact PI
Defining the regulatory roles of alternative ribosome initiation and novel peptides$248,999
R00 · FY2021 · GM · contact PI
Defining the regulatory roles of alternative ribosome initiation and novel peptides$50,000
K99 · FY2020 · GM · contact PI
Defining the regulatory roles of alternative ribosome initiation and novel peptides$100,000
K99 · FY2019 · GM · contact PI